256 related articles for article (PubMed ID: 24277047)
1. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.
Zhou Y; Zhang Y; Sheng Y; Zhang L; Shen Z; Chen Z
Antimicrob Agents Chemother; 2014; 58(2):1034-8. PubMed ID: 24277047
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
3. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
Ma Z; Zheng Y; Deng J; Ma X; Liu H
Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
5. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
[TBL] [Abstract][Full Text] [Related]
6. Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.
Wu HM; Wong KS; Huang YC; Lai SH; Tsao KC; Lin YJ; Lin TY
J Infect Chemother; 2013 Aug; 19(4):782-6. PubMed ID: 23196653
[TBL] [Abstract][Full Text] [Related]
7. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
9. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.
Matsuda K; Narita M; Sera N; Maeda E; Yoshitomi H; Ohya H; Araki Y; Kakuma T; Fukuoh A; Matsumoto K
BMC Infect Dis; 2013 Dec; 13():591. PubMed ID: 24330612
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae.
Guo D; Hu W; Xu B; Li J; Li D; Li S; Wu Z; Wei R; Tian X; Shen K; Xin D
BMC Infect Dis; 2019 Jul; 19(1):616. PubMed ID: 31299916
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
Kawai Y; Miyashita N; Kubo M; Akaike H; Kato A; Nishizawa Y; Saito A; Kondo E; Teranishi H; Ogita S; Tanaka T; Kawasaki K; Nakano T; Terada K; Ouchi K
Antimicrob Agents Chemother; 2013 May; 57(5):2252-8. PubMed ID: 23459497
[TBL] [Abstract][Full Text] [Related]
12. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.
Yoo SJ; Kim HB; Choi SH; Lee SO; Kim SH; Hong SB; Sung H; Kim MN
Antimicrob Agents Chemother; 2012 Dec; 56(12):6393-6. PubMed ID: 23006753
[TBL] [Abstract][Full Text] [Related]
13. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
15. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.
Deng H; Rui J; Zhao D; Liu F
J Int Med Res; 2018 Jan; 46(1):150-157. PubMed ID: 28760082
[TBL] [Abstract][Full Text] [Related]
16. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.
Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S
J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728
[TBL] [Abstract][Full Text] [Related]
17. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.
Ferguson GD; Gadsby NJ; Henderson SS; Hardie A; Kalima P; Morris AC; Hill AT; Cunningham S; Templeton KE
J Med Microbiol; 2013 Dec; 62(Pt 12):1876-1882. PubMed ID: 24008501
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.
Katsushima Y; Katsushima F; Suzuki Y; Seto J; Mizuta K; Nishimura H; Matsuzaki Y
Pediatr Int; 2015 Apr; 57(2):247-52. PubMed ID: 25265270
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Chen Y; Tian WM; Chen Q; Zhao HY; Huang P; Lin ZQ; Chen L
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Aug; 20(8):629-634. PubMed ID: 30111471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
